
The name matricryptin was proposed by Davis et al. (2000) for enzymatic fragments of extracellular matrix containing exposed matricryptic sites. The exposure of these sites occurred after structural or conformational modifications. Matricryptins derived from non fibrillar collagens (IV, VIII, XV and XVIII) and from matrix metalloproteinase-2 inhibit angiogenesis and tumor growth. Proteolysis of SPARC releases several peptides which exert opposite effects on angiogenesis. Matricryptins derived from glycosaminoglycans also participate in the control of angiogenesis.
Binding Sites, [SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology, Humans, Matrix Metalloproteinase 2, Neovascularization, Physiologic, Osteonectin, Non-Fibrillar Collagens, Extracellular Matrix
Binding Sites, [SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology, Humans, Matrix Metalloproteinase 2, Neovascularization, Physiologic, Osteonectin, Non-Fibrillar Collagens, Extracellular Matrix
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
